6-K 1 tm2312796d1_6k.htm FORM 6-K

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

 

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

 

For the month of April 2023

Commission file number: 001-32749

 

FRESENIUS MEDICAL CARE AG & Co. KGaA

(Translation of registrant's name into English)

 

Else-Kröner Strasse 1

61346 Bad Homburg

Germany

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x                    Form 40-F ¨

 

 

 

 

 

 

EXHIBITS

 

The following exhibits are being furnished with this Report:

 

Exhibit 99.1 Voting Instruction Card for holders of ADRs.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

DATE: April 13, 2023

 

    Fresenius Medical Care AG & Co. KGaA,
    a partnership limited by shares, represented by:
       
    fresenius medical care management ag, its
    General Partner
     
     
  By: /s/ Helen Giza
  Name: Helen Giza
  Title: Chief Executive Officer, Chair of the Management Board of the General Partner and Acting Chief Financial Officer
     
  By: /s/ Dr. Katarzyna Mazur-Hofsäß
  Name: Dr. Katarzyna Mazur-Hofsäß
  Title: CEO Care Enablement and member of the Management Board of the General Partner